Understanding how nicotine affects tobacco use and public health.
The Ohio State University Tobacco Center of Regulatory Science (OSU-TCORS)
['FUNDING_OTHER'] · OHIO STATE UNIVERSITY · NIH-10929345
This study looks at how the tobacco industry uses nicotine to make their products more addictive, especially for young people, and explores ways to help reduce tobacco use and keep everyone healthier.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OHIO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (Columbus, UNITED STATES) |
| Trial ID | NIH-10929345 on ClinicalTrials.gov |
What this research studies
This research investigates the role of nicotine in tobacco products, focusing on how the tobacco industry manipulates nicotine levels to increase addiction and usage among different demographics, particularly young people. It examines various nicotine delivery methods, including e-cigarettes and oral nicotine pouches, and how regulatory measures can be used to control these products' appeal and addiction potential. By analyzing the industry's strategies, the research aims to develop effective public health interventions to reduce tobacco use and improve population health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals under 21 years old who are current or potential users of tobacco products.
Not a fit: Patients who are not using tobacco products or are over the age of 21 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective regulations that reduce tobacco use and its associated health risks, particularly among young people.
How similar studies have performed: Previous research has shown that regulating nicotine levels can significantly impact tobacco use behaviors, indicating that this approach has potential for success.
Where this research is happening
Columbus, UNITED STATES
- OHIO STATE UNIVERSITY — Columbus, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WAGENER, THEODORE LEE — OHIO STATE UNIVERSITY
- Study coordinator: WAGENER, THEODORE LEE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.